ERBB2 and cancer: Besides 2Rs15d, three other HER2-targeting Nbs have undergone clinical translation to test their efficacy in diagnosing and monitoring HER2+ cancers undergoing targeted therapies: NM-02, MIRC208, and MIRC213.